We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

102 hedge funds and large institutions have $121M invested in VanEck Biotech ETF in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 30 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more call options, than puts

Call options by funds: $239K | Put options by funds: $211K

1.54% less ownership

Funds ownership: 29.97% → 28.43% (-1.5%)

6% less funds holding

Funds holding: 108 → 102 (-6)

8% less capital invested

Capital invested by funds: $132M → $121M (-$10.2M)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

37% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 30

Holders
102
Holders Change
-6
Holders Change %
-5.56%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
30
Closed
13
Calls
$239K
Puts
$211K
Net Calls
+$28K
Net Calls Change
+$261K

Top Buyers

Rank Fund Capital Flow
1
PGFC
Peapack-Gladstone Financial Corp
New Jersey
+$4.36M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.9M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.79M
4
JMPWA
JP Morgan Private Wealth Advisors
California
+$1.59M
5
LJAC
L.J. Altfest & Co
New York
+$846K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4.75M
2
CCA
Conservest Capital Advisors
Pennsylvania
-$3.49M
3
Morgan Stanley
Morgan Stanley
New York
-$1.88M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.64M
5
LPL Financial
LPL Financial
California
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
26
Raymond James & Associates
Florida
$1.18M -$72.6K -480 -5%
Wells Fargo
27
Wells Fargo
California
$1.11M +$279K +1,846 +30%
IFWM
28
Institute for Wealth Management
Colorado
$1.08M -$17.1K -113 -1%
Janney Montgomery Scott
29
Janney Montgomery Scott
Pennsylvania
$1.07M -$98.3K -650 -8%
PSF
30
Pacific Sun Financial
California
$880K +$4.84K +32 +0.5%
Ameriprise
31
Ameriprise
Minnesota
$873K +$56.2K +372 +6%
Stifel Financial
32
Stifel Financial
Missouri
$872K -$104K -690 -10%
SBH
33
Segall Bryant & Hamill
Illinois
$857K – – –
CAN
34
Cetera Advisor Networks
California
$843K -$186K -1,233 -17%
ACA
35
Atlas Capital Advisors
Wyoming
$802K – – –
GJIC
36
Gamble Jones Investment Counsel
California
$802K – – –
LJAC
37
L.J. Altfest & Co
New York
$788K +$846K +5,594 New
AL
38
Aspiriant LLC
California
$656K -$3.63K -24 -0.5%
PNC Financial Services Group
39
PNC Financial Services Group
Pennsylvania
$564K – – –
NWA
40
Navis Wealth Advisors
New York
$551K – – –
IAMOG
41
Investors Asset Management of Georgia
Georgia
$521K – – –
PWP
42
Pursue Wealth Partners
California
$493K -$317K -2,100 -38%
Truist Financial
43
Truist Financial
North Carolina
$485K – – –
BFC
44
Blue Fin Capital
Rhode Island
$444K – – –
TC
45
Telemus Capital
Michigan
$443K -$13.3K -88 -3%
MIM
46
Miller Investment Management
Pennsylvania
$428K +$215K +1,423 +88%
MML Investors Services
47
MML Investors Services
Massachusetts
$399K +$428K +2,833 New
TRCT
48
Tower Research Capital (TRC)
New York
$377K -$366K -2,422 -47%
WJWM
49
Williams Jones Wealth Management
New York
$374K – – –
AT
50
American Trust
Kentucky
$368K +$352K +2,328 New
1
2
3 4 5

BBH Hedge Fund Activity: Q3 2022 in Review

102 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2022, worth a combined $121M — down 7.8% from $132M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BBH and 10 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 19 added.

The largest buyer was Peapack-Gladstone Financial Corp, opening a new position worth an estimated $4.36M. The largest seller was Bank of America, cutting an estimated $4.75M.

  • 102 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2022, down from 108 in Q2 2022.
  • Funds reported $121M of VanEck Biotech ETF stock for Q3 2022, down 7.8% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q3 2022 and 13 closed out, a net change of -3 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2022 was Peapack-Gladstone Financial Corp, an estimated $4.36M added.
  • The largest VanEck Biotech ETF seller in Q3 2022 was Bank of America, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.